Sepsis-Induced Endothelial Barrier Dysfunction: Mechanisms, Pathology, and Therapeutic Advances

Research

DOI: 10.34133/research.0997 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 0 stored of 20

References 6

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
2022 The Lancet Respiratory Medicine article Medicine COVID-19 Clinical Research Studies Open access cited by 2 patents

154

citations
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
2021 The Lancet Respiratory Medicine article Medicine COVID-19 Clinical Research Studies Open access

125

citations
Integrin-Dependent Cell–Matrix Adhesion in Endothelial Health and Disease
2023 Circulation Research article Medicine Cell Adhesion Molecules Research Open access

123

citations
Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization
2021 Angiogenesis article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access

34

citations
Simultaneous C5 and CD14 inhibition limits inflammation and organ dysfunction in pig polytrauma
2022 Frontiers in Immunology article Medicine Trauma, Hemostasis, Coagulopathy, Resuscitation Open access

23

citations
Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial
2022 Frontiers in Medicine article Medicine Sepsis Diagnosis and Treatment Open access cited by 4 patents

22

citations

6 results